| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Puma Biotechnology, Inc. (PBYI) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. PBYI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 227.5K | $1.74M | - | |
| Other | 70.3K | $538.7K | - | |
| CFO | 66.5K | $509.7K | - | |
| Dir | 54.0K | $413.6K | - | |
| Dir | 41.9K | $320.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Senderowicz Adrian48 | Director | Sell | 27,000 | $3.40 | $91,800.00 | -50.0% | +34.3% | +118.8% | |
| Jun 13, 2025 | Dorval Allison | Director | Sell | 11,610 | $3.40 | $39,474.00 | -13.3% | +34.3% | +118.8% | |
| Jun 13, 2025 | Stuglik Brian M61 | Director | Sell | 8,100 | $3.39 | $27,459.00 | -7.9% | +34.3% | +118.8% | |
| Jun 13, 2025 | Wilson Troy Edward64 | Director | Sell | 10,800 | $3.40 | $36,720.00 | -19.9% | +34.3% | +118.8% | |
| Jan 2, 2025 | Nougues Maximo F61 | Chief Financial Officer | Sell | 10,227 | $3.15 | $32,232.44 | -6.3% | -3.5% | +84.9% | |
| Jan 2, 2025 | Ludwig Jeffrey Jerome57 | Chief Commercial Officer | Sell | 9,437 | $3.15 | $29,742.59 | -8.0% | -3.5% | +84.9% | |
| Jan 2, 2025 | Hunt Douglas M62 | See Remarks | Sell | 8,633 | $3.15 | $27,208.63 | -6.5% | -3.5% | +84.9% | |
| Jan 2, 2025 | Auerbach Alan H62 | President And CEO | Sell | 33,841 | $3.15 | $106,656.68 | -0.5% | -3.5% | +84.9% | |
| Aug 12, 2024 | Miller Michael Patrick46 | Director | Sell | 23,358 | $3.49 | $81,465.70 | -33.2% | -4.8% | +40.5% | |
| Jul 17, 2024 | Nougues Maximo F61 | Chief Financial Officer | Sell | 4,156 | $3.70 | $15,381.77 | -2.5% | -21.9% | -7.9% |